What is the goal for what we can hear today about the efficacy of Leronlimab?

According to the small (seemingly tiny) study done by Humanigen on Lenzilumab they seemed to have decreased the disease timeline significantly.

On Lenzilumab:
"Patients showed rapid clinical improvement with a median time to recovery of five days, median time to discharge of five days and 100% survival to the data cut-off date."

Is this what we are looking for? In comparison to 2 weeks... that seems amazing. However, again, it is a tiny study.

What would be the "break out" number? Meaning below is bad and above is good and the number is break even. Hard question but just curious... I know nothing about the meds but I am into the stats. I'm sure some of us are in that same boat. Unless you are all doctors... then I am in way over my head.

Even though I know nothing... I would think that as a stand alone drug, 3 days difference would be my break even. Meaning that recovery would happen at least three days earlier than those not taking meds... hopefully sooner. Mixed with Remdesivir double that to at least 6 days different. Hope those don't seem crazy.

I am really hoping that stats are missing from the meeting today...